Artificial Intelligence

Artificial intelligence (AI) is becoming a crucial component of healthcare to help augment physicians and make them more efficient. In medical imaging, it is helping radiologists more efficiently manage PACS worklists, enable structured reporting, auto detect injuries and diseases, and to pull in relevant prior exams and patient data. In cardiology, AI is helping automate tasks and measurements on imaging and in reporting systems, guides novice echo users to improve imaging and accuracy, and can risk stratify patients. AI includes deep learning algorithms, machine learning, computer-aided detection (CAD) systems, and convolutional neural networks. 

RSS icon
healthcare AI return on investment ROI

Number-cruncher quantifies return on investment in healthcare AI

Just by taking notes during patient visits, generative AI could save a five-physician primary care practice $291,200 in one year. The practice would see a return on its AI investment of 94.13% and reach the breakeven point in a bit more than six months. 

robot reviewing heart data

Viz.ai partners with Cleerly in the name of AI-based CCTA evaluations

The new partnership is focused on getting advanced AI algorithms into the hands of cardiologists.

Healthcare CIO on the job

Today’s healthcare CIO: Enterprise strategist or technology tactician?

A new survey shows that, in the generative AI era, two of every three U.S. hospitals let the CIO’s office handle the selection and acquisition of data analytics platforms.

How can the world’s AI stakeholders work together toward the common goal of international scientific agreement on AI’s risks?

International experts formulate scientific approach to AI risk management

A lot of people from a lot of organizations in a lot of countries are working to coordinate oversight of AI’s risks. A budding project seeks to bring many of these minds together to advance the worthy goal of building global consensus with scientific rigor.

Brittany Nicole Weber, MD, Brigham and Women's Hospital, explains the use of opportunistic CT screening for cardiovascular disease on noncardiac exams.

Opportunistic screening with AI could be a game-changer for preventive cardiology

Brittany Nicole Weber, MD, PhD, detailed new research into the benefits of screening for cardiovascular disease in CT scans not specifically ordered for that purpose. The rise of AI has helped make opportunistic screening a huge trend in both cardiology and radiology. 

artificial intelligence AI money brain dollar

Johns Hopkins, CareFirst partner with venture capital for ‘AI accelerator’ program

The 13-week course will be held in Baltimore sometime in March 2025. Healthcare AI startups have until Nov. 20 to apply.

AI and patient care are top of mind for healthcare executives in 2024

C-suite surveyors: AI ‘continues to excite healthcare leaders’

AI and patient care are “top of mind” for healthcare executives in 2024. The pairing seems opportune, since the surveyed leaders see the burgeoning technology as a key tool for improving the perennial mission.

Dana Smetherman, MD, explains the ACR take on the growing radiology staffing shortage.

Radiology workforce shortage a major concern for the American College of Radiology

Dana H. Smetherman, MD, MBA, CEO of the ACR, discusses the reasons behind the worsening shortage of radiologists, along with possible solutions. 

Displaying 57 - 64 of 978

Around the web

Cardiovascular Business
Why electrophysiologists needed a champion in Washington

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.

Cardiovascular Business
Reimbursement update: What hospitals need to know about new Medicare payments for cardiac CT

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Cardiovascular Business
Stryker acquires Inari Medical for $4.9B

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.